Diseases & Illness |

Hepatitis News

Study of New Hepatitis C Drug Halted

RSS News Feeds
Disease from Products
Hepatitis
 All RSS Feeds

At a glance:

Anadys Pharmaceuticals has halted a clinical study of a Hepatitis C drug. Although the 17 patients in the study had no adverse effects, new results on animal studies suggested that the drug may overstimulate the immune system. 
 
The company's stock was downgraded after the announcement.

Anadys Pharma Dives on Halted Study

MSN Money - 6/26/2006 2:13 PM

SAN DIEGO (AP) - Shares of Anadys Pharmaceuticals Inc. lost nearly half their value in midday trading Monday after the company said it suspended an early-stage study on its hepatitis C treatment candidate over safety concerns.
 
Shares shed $3.24, or 48.4 percent, slumping to $3.45. The stock tumbled as low as $2.98 at one point, setting a record low for the drug developer with trading volume surging to 20 times its average. The stock's all-time high of $16.60 came March 30
 
· Read The Full Hepatitis Article From MSN Money -->

· Read All Hepatitis News Stories -->

Comments On Hepatitis News Articles:

thank u
Comment On: Study of New Hepatitis C Drug Halted
Posted by isrel tunde on 8/30/2006 | Filed Under: Hepatitis

i apprecite every bit of what i read about hepatitis infact it is in detail or reseach.


Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: